ESHRE guideline: endometriosis
AbstractThe current guideline provides 109 recommendations on diagnosis, treatments for pain and infertility, management of disease recurrence, asymptomatic or extrapelvic disease, endometriosis in adolescents and postmenopausal women, prevention and the association with cancer.
What is known already. Endometriosis is a chronic condition with a plethora of presentations in terms of not only the occurrence of lesions, but also the presence of signs and symptoms. The most important symptoms include pain and infertility.
Study design, size, duration. The guideline was developed according to the structured methodology for development of ESHRE guidelines. After formulation of key questions by a group of experts, literature searches and assessments were performed. Papers published up to 1 December 2020 and written in English were included in the literature review.
Participants/materials, setting, methods. Based on the collected evidence, recommendations were formulated and discussed within specialist subgroups and then presented to the core guideline development group (GDG) until consensus was reached. A stakeholder review was organized after finalization of the draft. The final version was approved by the GDG and the ESHRE Executive Committee.
Main results and the role of chance. This guideline aims to help clinicians to apply best care for women with endometriosis. Although studies mostly focus on women of reproductive age, the guideline also addresses endometriosis in adolescents and postmenopausal women. The guideline outlines the diagnostic process for endometriosis, which challenges laparoscopy and histology as gold standard diagnostic tests. The options for treatment of endometriosis-associated pain symptoms include analgesics, medical treatments and surgery. Non-pharmacological treatments are also discussed. For management of endometriosis-associated infertility, surgical treatment and/or medically assisted reproduction are feasible. While most of the more recent studies confirm previous ESHRE recommendations, there are fivetopics in which significant changes to recommendations were required and changes in clinical practice are to be expected.
Limitations, reasons for caution. The guideline describes different management options but, based on existing evidence, no firm recommendations could be formulated on the most appropriate treatments. Also, for specific clinical issues, such as asymptomatic endometriosis or extrapelvic endometriosis, the evidence is too scarce to make evidence-based recommendations.
Wider implications of the findings. The guideline provides clinicians with clear advice on best practice in endometriosis care, based on the best evidence currently available. In addition, a list of research recommendations is provided to stimulate further studies in endometriosis.
Keywords:endometriosis; guideline; fertility; pelvic pain; adolescent; surgery; ESHRE guideline
Norgaard-Pedersen C., Nielsen K., Steffensen R., et al. Intravenous immunoglobulin
and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive
technology treatment: a protocol for a randomised, double- blind, placebo- controlled trial.
BMJ Open 2022; 12: e064780. DOI: https://doi.org/10.1136/bmjopen-2022-064780
Литература/References
Abdou A.M., Ammar I.M.M., Alnemr A.A.A., Abdelrhman A.A. Dienogest versus leuprolide acetate for recurrent pelvic pain following laparoscopic treatment of endometriosis. J Obstet Gynaecol India. 2018; 68: 306–13.
Agarwal S.K., Foster W.G. Reduction in endometrioma size with three months of aromatase inhibition and progestin add-back. Biomed Res Int. 2015; 2015: 878517.
Alborzi S., Hamedi B., Omidvar A., Dehbashi S., Alborzi S., Alborzi M. A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol Obstet. 2011; 284: 105–10.
Alborzi S., Zahiri Sorouri Z., Askari E., Poordast T., Chamanara K. The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies. Reprod Med Biol. 2019; 18: 312–22.
Alcázar J.L., Castillo G., Jurado M., García G.L. Is expectant management of sonographically benign adnexal cysts an option in selected asymptomatic premenopausal women? Hum Reprod. 2005; 20: 3231–4.
Almassinokiani F., Almasi A., Akbari P., Saberifard M. Effect of letrozole on endometriosis-related pelvic pain. Med J Islam Repub Iran. 2014; 28: 107.
Alshehre S.M., Narice B.F., Fenwick M.A., Metwally M. The impact of endometrioma on in vitro fertilisation/intra-cytoplasmic injection IVF/ICSI reproductive outcomes: A systematic review and meta-analysis. Arch Gynecol Obstet. 2021; 303: 3–16.
Andres M.D.P., Lopes L.A., Baracat E.C., Podgaec S. Dienogest in the treatment of endometriosis: Systematic review. Arch Gynecol Obstet. 2015; 292: 523–9.
Andres M.P., Arcoverde F.V.L., Souza C.C.C., Fernandes L.F.C, Abrao M.S., Kho R.M. Extrapelvic endometriosis: A systematic review. J Minim Invasive Gynecol. 2020; 27: 373–89.
Arcoverde F.V.L., Andres M.P., Borrelli G.M., Barbosa P.A., Abrao M.S., Kho R.M. Surgery for endometriosis improves major domains of quality of life: A systematic review and meta-analysis. J Minim Invasive Gynecol. 2019; 26: 266–78.
Bafort C., Beebeejaun Y., Tomassetti C., Bosteels J., Duffy J.M.N.; Cochrane Gynaecology and Fertility Group. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2020; 10: CD011031.
Ballard K.D., Seaman H.E., de Vries C.S., Wright J.T. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study-part 1. BJOG. 2008; 115: 1382–91.
Bastu E., Yasa C., Dural O., Mutlu M.F., Celik C., Ugurlucan F.G., et al. Comparison of ovulation induction protocols after endometrioma resection. JSLS. 2014; 18: e2014.00128.
Bazot M., Lafont C., Rouzier R., Roseau G., Thomassin-Naggara I., Darai E. Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. Fertil Steril. 2009; 92: 1825–33.
Behera M., Vilos G.A., Hollett-Caines J., Abu-Rafea B., Ahmad R. Laparoscopic findings, histopathologic evaluation, and clinical outcomes in women with chronic pelvic pain after hysterectomy and bilateral salpingo-oophorectomy. J Minim Invasive Gynecol. 2006; 13: 431–5.
Benaglia L., Somigliana E., Iemmello R., Colpi E., Nicolosi A.E., Ragni G. Endometrioma and oocyte retrieval-induced pelvic abscess: A clinical concern or an exceptional complication? Fertil Steril. 2008; 89: 1263–6.
Bendifallah S., Roman H., Mathieu d’Argent E., Touleimat S., Cohen J., Darai E., et al. Colorectal endometriosis-associated infertility: Should surgery precede ART? Fertil Steril. 2017; 108: 525–31.e4.
Bendifallah S., Vesale E., Darai E., Thomassin-Naggara I., Bazot M., Tuech J.J., et al. Recurrence after surgery for colorectal endometriosis: A systematic review and meta-analysis. J Minim Invasive Gynecol. 2020; 27: 441–51.e2.
Berlanda N., Somigliana E., Vigano P., Vercellini P. Safety of medical treatments for endometriosis. Expert Opin Drug Saf. 2016; 15: 21–30.
Bianchi P.H., Pereira R.M., Zanatta A., Alegretti J.R., Motta E.L., Serafini P.C. Extensive excision of deep infiltrative endometriosis before in vitro fertilization significantly improves pregnancy rates. J Minim Invasive Gynecol. 2009; 16: 174–80.
Braganza M.Z., de Gonzalez A.B., Schonfeld S.J., Wentzensen N., Brenner A.V., Kitahara C.M. Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. Cancer Prev Res (Phila). 2014; 7: 418–25.
Bravi F., Parazzini F., Cipriani S., Chiaffarino F., Ricci E., Chiantera V., et al. Tobacco smoking and risk of endometriosis: A systematic review and meta-analysis. BMJ Open. 2014; 4: e006325.
Breteau P., Chanavaz-Lacheray I., Rubod C., Turck M., Sanguin S., Pop I., et al. Pregnancy rates after surgical treatment of deep infiltrating endometriosis in infertile patients with at least 2 previous in vitro fertilization or intracytoplasmic sperm injection failures. J Minim Invasive Gynecol. 2020; 27: 1148–57.
Brosens I., Gordts S., Benagiano G. Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion. Hum Reprod. 2013; 28: 2026–31.
Brown J., Crawford T.J., Allen C., Hopewell S., Prentice A. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2017; 1: CD004753.
Brown J., Crawford T.J., Datta S., Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2018; 5: CD001019.
Brown J., Kives S., Akhtar M.; Cochrane Gynaecology and Fertility Group. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev. 2012; 3: CD002122.
Brown J., Pan A., Hart R.J. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010; 12: CD008475.
Busacca M., Riparini J., Somigliana E., Oggioni G., Izzo S., Vignali M., et al. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol. 2006; 195: 421–5.
Butt S.A., Lidegaardi O., Skovlund C., Hannaford P.C., Iversen L., Fielding S., et al. Hormonal contraceptive use and risk of pancreatic cancer: A cohort study among premenopausal women. PLoS One. 2018; 13: e0206358.
Byrne D., Curnow T., Smith P., Cutner A., Saridogan E., Clark T.J.; BSGE Endometriosis Centres. Laparoscopic excision of deep rectovaginal endometriosis in BSGE endometriosis centres: A multicentre prospective cohort study. BMJ Open. 2018; 8: e018924.
Candiani G.B., Fedele L., Vercellini P., Bianchi S., Di Nola G. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol. 1991; 77: 421–4.
Candiani M., Ottolina J., Schimberni M., Tandoi I., Bartiromo L., Ferrari S. Recurrence rate after «One-Step» CO(2) fiber laser vaporization versus cystectomy for ovarian endometrioma: A 3-year follow-up study. J Minim Invasive Gynecol 2020;27:901-908.
Cao X., Chang H.-Y., Xu J.-Y., Zheng Y., Xiang Y.-G., Xiao B., et al. The effectiveness of different downregulating protocols on in vitro fertilization-embryo transfer in endometriosis: A meta-analysis. Reprod Biol Endocrinol. 2020; 18: 16.
Carmona F., Martinez-Zamora M.A., Rabanal A., Martinez-Roman S., Balasch J. Ovarian cystectomy versus laser vaporization in the treatment of ovarian endometriomas: A randomized clinical trial with a five-year follow-up. Fertil Steril. 2011; 96: 251–4.
Ceccaroni M., Roviglione G., Giampaolino P., Clarizia R., Bruni F., Ruffo G., et al. Laparoscopic surgical treatment of diaphragmatic endometriosis: A 7-year single-institution retrospective review. Surg Endosc. 2013; 27: 625–32.
Chapron C., Dubuisson J.B., Pansini V., Vieira M., Fauconnier A., Barakat H. et al. Routine clinical examination is not sufficient for diagnosing and locating deeply infiltrating endometriosis. J Am Assoc Gynecol Laparosc. 2002; 9: 115–9.
Chapron C., Lafay-Pillet M.C., Monceau E., Borghese B., Ngo C., Souza C., et al. Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis. Fertil Steril. 2011; 95: 877–81.
Chapron C., Querleu D., Bruhat M.A., Madelenat P., Fernandez H., Pierre F., et al. Surgical complications of diagnostic and operative gynaecological laparoscopy: A series of 29,966 cases. Hum Reprod. 1998; 13: 867–72.
Chen F.P., Soong Y.K., Lee N., Lo S.K. The use of serum CA-125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand. 1998; 77: 665–70.
Chen I., Veth V.B., Choudhry A.J., Murji A., Zakhari A., Black A.Y., et al. Pre- and postsurgical medical therapy for endometriosis surgery. Cochrane Database Syst Rev. 2020; 11: CD003678.
Ciriaco P., Muriana P., Lembo R., Carretta A., Negri G. Treatment of thoracic endometriosis syndrome: A meta-analysis and review. Ann Thorac Surg. 2022; 113: 324–36.
Clayton R.D., Hawe J.A., Love J.C., Wilkinson N., Garry R. Recurrent pain after hysterectomy and bilateral salpingo-oophorectomy for endometriosis: evaluation of laparoscopic excision of residual endometriosis. Br J Obstet Gynaecol. 1999; 106: 740–4.
Cobo A., Giles J., Paolelli S., Pellicer A., Remohi J., Garcia-Velasco J.A. Oocyte vitrification for fertility preservation in women with endometriosis: An observational study. Fertil Steril. 2020; 113: 836–44.
Coccia M.E., Rizzello F., Barone S., Pinelli S., Rapalini E., Parri C., et al. Is there a critical endometrioma size associated with reduced ovarian responsiveness in assisted reproduction techniques? Reprod Biomed Online. 2014; 29: 259–66.
Condous G., Van Calster B., Van Huffel S., Lam A. What is the value of preoperative bimanual pelvic examination in women undergoing laparoscopic total hysterectomy? J Minim Invasive Gynecol. 2007; 14: 334–8.
Cosar E., Mamillapalli R., Ersoy G.S., Cho S., Seifer B., Taylor H.S. Serum microRNAs as diagnostic markers of endometriosis: A comprehensive array-based analysis. Fertil Steril. 2016; 106: 402–9.
Dan H., Limin F. Laparoscopic ovarian cystectomy versus fenestration/coagulation or laser vaporization for the treatment of endometriomas: A meta-analysis of randomized controlled trials. Gynecol Obstet Invest. 2013; 76: 75–82.
Davis A.R., Westhoff C., O’Connell K., Gallagher N. Oral contraceptives for dysmenorrhea in adolescent girls: A randomized trial. Obstet Gynecol. 2005; 106: 97–104.
De Cicco C., Corona R., Schonman R., Mailova K., Ussia A., Koninckx P. Bowel resection for deep endometriosis: A systematic review. BJOG. 2011; 118: 285–91.
de Ziegler D., Gayet V., Aubriot F.X., Fauque P., Streuli I., Wolf J.P., et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril. 2010; 94: 2796–9.
DiVasta A.D., Feldman H.A., Sadler Gallagher J., Stokes N.A., Laufer M.R., Hornstein M.D., et al. Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: A randomized controlled trial. Obstet Gynecol. 2015; 126: 617–27.
DiVasta A.D., Vitonis A.F., Laufer M.R., Missmer S.A. Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood. Am J Obstet Gynecol. 2018; 218: 324.e1–11.
Donnez J., Taylor H.S., Taylor R.N., Akin M.D., Tatarchuk T.F., Wilk K., et al. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: A randomized clinical trial. Fertil Steril. 2020; 114: 44–55.
Doyle J.O., Missmer S.A., Laufer M.R. The effect of combined surgical-medical intervention on the progression of endometriosis in an adolescent and young adult population. J Pediatr Adolesc Gynecol. 2009; 22: 257–63.
Dragoman M.V., Gaffield M.E. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review. Contraception. 2016; 94: 202–15.
Drakopoulos P., Rosetti J., Pluchino N., Blockeel C., Santos-Ribeiro S., de Brucker M., et al. Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage? Gynecol Endocrinol. 2018; 34: 884–9.
Dunselman G.A.J., Vermeulen N., Becker C., Calhaz-Jorge C., D’Hooghe T., De Bie B., et al.; European Society of Human Reproduction and Embryology. ESHRE guideline: Management of women with endometriosis. Hum Reprod. 2014; 29: 400–12.
Ebert A.D., Dong L., Merz M., Kirsch B., Francuski M., Bottcher B., et al. Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: The VISanne study to Assess safety in ADOlescents. J Pediatr Adolesc Gynecol. 2017; 30: 560–7.
Eskenazi B., Warner M., Bonsignore L., Olive D., Samuels S., Vercellini P. Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril. 2001; 76: 929–35.
Eskenazi B., Warner M.L. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997; 24: 235–58.
Ferrero S., Gillott D.J., Venturini P.L., Remorgida V. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: A systematic review. Reprod Biol Endocrinol. 2011; 9: 89.
Forman R.G., Robinson J.N., Mehta Z., Barlow D.H. Patient history as a simple predictor of pelvic pathology in subfertile women. Hum Reprod. 1993; 8: 53–5.
Franck C., Poulsen M.H., Karampas G., Giraldi A., Rudnicki M. Questionnaire-based evaluation of sexual life after laparoscopic surgery for endometriosis: A systematic review of prospective studies. Acta Obstet Gynecol Scand. 2018; 97: 1091–104.
Gallagher J.S., Feldman H.A., Stokes N.A., Laufer M.R., Hornstein M.D., Gordon C.M., et al. The effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life for adolescents with endometriosis: A randomized controlled trial. J Pediatr Adolesc Gynecol. 2017; 30: 215–22.
Gallagher J.S., Missmer S.A., Hornstein M.D., Laufer M.R., Gordon C.M., DiVasta A.D. Long-term effects of gonadotropin-releasing hormone agonists and add-back in adolescent endometriosis. J Pediatr Adolesc Gynecol. 2018; 31: 376–81.
Gemmell L.C., Webster K.E., Kirtley S., Vincent K., Zondervan K.T., Becker C.M. The management of menopause in women with a history of endometriosis: A systematic review. Hum Reprod Update. 2017; 23: 481–500.
Georgiou E.X., Melo P., Baker P.E., Sallam H.N., Arici A., Garcia-Velasco J.A., et al. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Cochrane Database Syst Rev. 2019; 11: CD013240.
Geysenbergh B., Dancet E.A.F., D’Hooghe T. Detecting endometriosis in adolescents: why not start from self-report screening questionnaires for adult women? Gynecol Obstet Invest. 2017; 82: 322–8.
Gierisch J.M., Coeytaux R.R., Urrutia R.P., Havrilesky L.J., Moorman P.G., Lowery W.J., et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: A systematic review. Cancer Epidemiol Biomarkers Prev. 2013; 22: 1931–43.
Gil Y., Tulandi T. Diagnosis and treatment of catamenial pneumothorax: A systematic review. J Minim Invasive Gynecol. 2020; 27: 48–53.
Glavind M.T., Mollgaard M.V., Iversen M.L., Arendt L.H., Forman A. Obstetrical outcome in women with endometriosis including spontaneous hemoperitoneum and bowel perforation: A systematic review. Best Pract Res Clin Obstet Gynaecol. 2018; 51: 41–52.
Grandi G., Barra F., Ferrero S., Sileo F.G., Bertucci E., Napolitano A., et al. Hormonal contraception in women with endometriosis: A systematic review. Eur J Contracept Reprod Health Care. 2019; 24: 61-70.
Greene R., Stratton P., Cleary S.D., Ballweg M.L., Sinaii N. Diagnostic experience among 4,334 women reporting surgically diagnosed endometriosis. Fertil Steril. 2009; 91: 32–9.
Guerriero S., Saba L., Ajossa S., Peddes C., Angiolucci M., Perniciano M., et al. Three-dimensional ultrasonography in the diagnosis of deep endometriosis. Hum Reprod. 2014; 29: 1189–98.
Gupta D., Hull M.L., Fraser I., Miller L., Bossuyt P.M., Johnson N., et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016; 4: CD012165.
Hamdan M., Dunselman G., Li T.C., Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: A systematic review and meta-analysis. Hum Reprod Update. 2015; 21: 809–25.
Hamdan M., Omar S.Z., Dunselman G., Cheong Y. Influence of endometriosis on assisted reproductive technology outcomes: A systematic review and meta-analysis. Obstet Gynecol. 2015; 125: 79–88.
Hansen S.O., Knudsen U.B. Endometriosis, dysmenorrhoea and diet. Eur J Obstet Gynecol Reprod Biol. 2013; 169: 162–71.
Haraguchi H., Koga K., Takamura M., Makabe T., Sue F., Miyashita M., et al. Development of ovarian cancer after excision of endometrioma. Fertil Steril. 2016; 106: 1432–7.
Harb H.M., Gallos I.D., Chu J., Harb M., Coomarasamy A. The effect of endometriosis on in vitro fertilisation outcome: A systematic review and meta-analysis. BJOG. 2013; 120: 1308–20.
Harris H.R., Eke A.C., Chavarro J.E., Missmer S.A. Fruit and vegetable consumption and risk of endometriosis. Hum Reprod. 2018; 33: 715–27.
Hart R.J., Hickey M., Maouris P., Buckett W.; Cochrane Gynaecology and Fertility Group. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008; 2: CD004992.
Havrilesky L.J., Moorman P.G., Lowery W.J., Gierisch J.M., Coeytaux R.R., Urrutia R.P., et al. Oral contraceptive pills as primary prevention for ovarian cancer: A systematic review and meta-analysis. Obstet Gynecol. 2013; 122: 139–47.
Healey M., Cheng C., Kaur H. To excise or ablate endometriosis? A prospective randomized double-blinded trial after 5-year follow-up. J Minim Invasive Gynecol. 2014; 21: 999–1004.
Hee L., Kettner L.O., Vejtorp M. Continuous use of oral contraceptives: An overview of effects and side-effects. Acta Obstet Gynecol Scand. 2013; 92: 125–36.
Hirata T., Koga K., Kitade M., Fukuda S., Neriishi K., Taniguchi F., et al. A national survey of umbilical endometriosis in Japan. J Minim Invasive Gynecol. 2020; 27: 80–7.
Hirsch M., Duffy J., Davis C.J., Nieves Plana M., Khan K.S.; on behalf of the International Collaboration to Harmonise Outcomes and Measures for Endometriosis. Diagnostic accuracy of cancer antigen 125 for endometriosis: A systematic review and meta-analysis. BJOG. 2016; 123: 1761–8.
Hodgson R.M., Lee H.L., Wang R., Mol B.W., Johnson N. Interventions for endometriosis-related infertility: A systematic review and network meta-analysis. Fertil Steril. 2020; 113: 374–82.
Hornstein M.D., Yuzpe A.A., Burry K., Buttram V.C. Jr, Heinrichs L.R., Soderstrom R.M., et al. Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density. Fertil Steril. 1997; 67: 1013–8.
Horton J., Sterrenburg M., Lane S., Maheshwari A., Li T.C., Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: A systematic review and meta-analysis. Hum Reprod Update. 2019; 25: 592–632.
Horton J.D., Dezee K.J., Ahnfeldt E.P., Wagner M. Abdominal wall endometriosis: A surgeon’s perspective and review of 445 cases. Am J Surg. 2008; 196: 207–12.
Hudelist G., Ballard K., English J., Wright J., Banerjee S., Mastoroudes H., et al. Transvaginal sonography vs clinical examination in the preoperative diagnosis of deep infiltrating endometriosis. Ultrasound Obstet Gynecol. 2011; 37: 480–7.
Hughes E., Brown J., Collins J.J., Farquhar C., Fedorkow D.M., Vanderkerchove P.; Cochrane Gynaecology and Fertility Group. Ovulation suppression for endometriosis for women with subfertility. Cochrane Database Syst Rev. 2007; 3: CD000155.
International Working Group of AAGL, ESGE, ESHRE and WES; Tomassetti C., Johnson N.P., Petrozza J., Abrao M.S., Einarsson J.I., Horne A.W., et al. An international terminology for endometriosis, 2021. Hum Reprod Open. 2021; 2021: hoab029.
Iversen M.L., Seyer-Hansen M., Forman A. Does surgery for deep infiltrating bowel endometriosis improve fertility? A systematic review. Acta Obstet Gynecol Scand. 2017; 96: 688–93.
Janssen E.B., Rijkers A.C., Hoppenbrouwers K., Meuleman C., D’Hooghe T.M. Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: A systematic review. Hum Reprod Update. 2013; 19: 570–82.
Jensen J.T., Schlaff W., Gordon K. Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: A systematic review of the evidence. Fertil Steril. 2018; 110: 137–52.
Jin X., Ruiz Beguerie J. Laparoscopic surgery for subfertility related to endometriosis: A meta-analysis. Taiwan J Obstet Gynecol. 2014; 53: 303–8.
Joseph J., Sahn S.A. Thoracic endometriosis syndrome: new observations from an analysis of 110 cases. Am J Med. 1996; 100: 164–70.
Kaponis A., Chatzopoulos G., Paschopoulos M., Georgiou I., Paraskevaidis V., Zikopoulos K., et al. Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: A prospective, randomized, controlled trial. Fertil Steril. 2020; 113: 828–35.
Kennedy S., Bergqvist A., Chapron C., D’Hooghe T., Dunselman G., Greb R., et al.; ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005; 20: 2698–704.
Khawaja U.B., Khawaja A.A., Gowani S.A., Shoukat S., Ejaz S., Ali F.N., et al. Frequency of endometriosis among infertile women and association of clinical signs and symptoms with the laparoscopic staging of endometriosis. J Pak Med Assoc. 2009; 59: 30–4.
Kim S.J., Kim S.K., Lee J.R., Suh C.S., Kim S.H. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis. Reprod Biomed Online. 2020; 40: 827–34.
Kohl Schwartz A.S., Wolfler M.M., Mitter V., Rauchfuss M., Haeberlin F., Eberhard M., et al. Endometriosis, especially mild disease: A risk factor for miscarriages. Fertil Steril. 2017; 108: 806–814.e2.
Kolanska K., Cohen J., Bendifallah S., Selleret L., Antoine J.M., Chabbert-Buffet N., et al. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis- associated infertility: GnRH-agonist versus GnRH-antagonist. J Gynecol Obstet Hum Reprod. 2017; 46: 681–6.
Koninckx P.R., Meuleman C., Oosterlynck D., Cornillie F.J. Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration. Fertil Steril. 1996; 65: 280–7.
Koshiba A., Mori T., Okimura H., Akiyama K., Kataoka H., Takaoka O., et al. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries. J Obstet Gynaecol Res. 2018; 44: 1970–6.
Kvaskoff M., Mahamat-Saleh Y., Farland L.V., Shigesi N., Terry K.L., Harris H.R., et al. Endometriosis and cancer: A systematic review and meta-analysis. Hum Reprod Update. 2021; 27: 393–420.
Lalani S., Choudhry A.J., Firth B., Bacal V., Walker M., Wen S.W, et al. Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis. Hum Reprod. 2018; 33: 1854–65.
Lan S., Ling L., Jianhong Z., Xijing J., Lihui W. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis. J Int Med Res. 20l3; 41: 548–58.
Lee K.H., Jung Y.W., Song S.Y., Kang B.H., Yang J.B., Ko Y.B., et al. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis. J Obstet Gynaecol Res. 2018; 44: 1779–86.
Lee S.Y., Kim M.L., Seong S.J., Bae J.W., Cho Y.J. Recurrence of ovarian endometrioma in adolescents after conservative, laparoscopic cyst enucleation. J Pediatr Adolesc Gynecol. 2017; 30: 228–33.
Leeners B., Damaso F., Ochsenbein-Kolble N., Farquhar C. The effect of pregnancy on endometriosis-facts or fiction? Hum Reprod Update. 2018; 24: 290–9.
Leone Roberti Maggiore U., Ferrero S., Mangili G., Bergamini A., Inversetti A., Giorgione V., et al. A systematic review on endometriosis during pregnancy: Diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update. 2016; 22: 70–103.
Leone Roberti Maggiore U., Inversetti A., Schimberni M., Vigano P., Giorgione V., Candiani M. Obstetrical complications of endometriosis, particularly deep endometriosis. Fertil Steril. 2017; 108: 895–912.
Lier M.C.I., Malik R.F., Ket J.C.F., Lambalk C.B., Brosens I.A., Mijatovic V. Spontaneous hemoperitoneum in pregnancy (SHiP) and endometriosis: A systematic review of the recent literature. Eur J Obstet Gynecol Reprod Biol. 2017; 219: 57–65.
Liu E., Nisenblat V., Farquhar C., Fraser I., Bossuyt P.M., Johnson N., et al. Urinary biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2015; 12: CD012019.
Lu D., Song H., Li Y., Clarke J., Shi G. Pentoxifylline for endometriosis. Cochrane Database Syst Rev. 2012; 1: CD007677.
Manganaro L., Fierro F., Tomei A., Irimia D., Lodise P., Sergi M.E., et al. Feasibility of 3.0T pelvic MR imaging in the evaluation of endometriosis. Eur J Radiol. 2012; 81: 1381–7.
Maouris P. Asymptomatic mild endometriosis in infertile women: the case for expectant management. Obstet Gynecol Surv. 1991; 46: 548–51.
Margatho D., Carvalho N.M., Bahamondes L. Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months. Eur J Contracept Reprod Health Care. 2020; 25: 133–40.
Martire F.G., Lazzeri L., Conway F., Siciliano T., Pietropolli A., Piccione E., et al. Adolescence and endometriosis: Symptoms, ultrasound signs and early diagnosis. Fertil Steril. 2020; 114: 1049–57.
Matalliotakis I., Makrigiannakis A., Karkavitsas N., Psaroudakis E., Froudarakis G., Koumantakis E. Use of CA-125 in the diagnosis and management of endometriosis: influence of treatment with danazol. Int J Fertil Menopausal Stud. 1994; 39: 100–4.
Matorras R., Elorriaga M.A., Pijoan J.I., Ramon O., Rodriguez-Escudero F.J. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril. 2002; 77: 303–8.
May K.E., Conduit-Hulbert S.A., Villar J., Kirtley S., Kennedy S.H., Becker C.M. Peripheral biomarkers of endometriosis: A systematic review. Hum Reprod Update. 2010; 16: 651–74.
May K.E., Villar J., Kirtley S., Kennedy S.H., Becker C.M. Endometrial alterations in endometriosis: A systematic review of putative biomarkers. Hum Reprod Update. 2011; 17: 637–53.
Melin A.S., Lundholm C., Malki N., Swahn M.L., Sparen P., Bergqvist A. Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer. Acta Obstet Gynecol Scand. 2013; 92: 546–54.
Meuleman C., Tomassetti C., D’Hoore A., Van Cleynenbreugel B., Penninckx F., Vergote I., et al. Surgical treatment of deeply infiltrating endometriosis with colorectal involvement. Hum Reprod Update. 2011; 17: 311–26.
Meuleman C., Vandenabeele B., Fieuws S., Spiessens C., Timmerman D., D’Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009; 92: 68–74.
Michels K.A., Pfeiffer R.M., Brinton L.A., Trabert B. Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers. JAMA Oncol. 2018; 4: 516–21.
Miller L.E., Bhattacharyya R., Miller V.M. Clinical utility of presacral neurectomy as an adjunct to conservative endometriosis surgery: Systematic review and meta-analysis of controlled studies. Sci Rep. 2020; 10: 6901.
Moen M.H., Stokstad T. A long-term follow-up study of women with asymptomatic endometriosis diagnosed incidentally at sterilization. Fertil Steril. 2002; 78: 773–6.
Mol B.W., Bayram N., Lijmer J.G., Wiegerinck M.A., Bongers M.Y., van der Veen F., et al. The performance of CA-125 measurement in the detection of endometriosis: A meta-analysis. Fertil Steril. 1998; 70: 1101–8.
Momoeda M., Harada T., Terakawa N., Aso T., Fukunaga M., Hagino H., et al. Long-term use of dienogest for the treatment of endometriosis. J Obstet Gynaecol Res. 2009; 35: 1069–76.
Morotti M., Remorgida V., Venturini P.L., Ferrero S. Endometriosis in menopause: A single institution experience. Arch Gynecol Obstet. 2012; 286: 1571–5.
Mossa B., Ebano V., Tucci S., Rega C., Dolce E., Frega A., Marziani R. Laparoscopic surgery for the management of ovarian endometriomas. Med Sci Monit. 2010; 16: MT45-50.
Moura A.P.C., Ribeiro H.S.A.A., Bernardo W.M., Simoes R., Torres U.S., D’Ippolito G., et al. Accuracy of transvaginal sonography versus magnetic resonance imaging in the diagnosis of rectosigmoid endometriosis: Systematic review and meta-analysis. PLoS One. 2019; 14: e0214842.
Moustafa S., Burn M., Mamillapalli R., Nematian S., Flores V., Taylor H.S. Accurate diagnosis of endometriosis using serum microRNAs. Am J Obstet Gynecol. 2020; 223: 557.e1–11.
Murta M., Machado R.C., Zegers-Hochschild F., Checa M.A., Sampaio M., Geber S. Endometriosis does not affect live birth rates of patients submitted to assisted reproduction techniques: Analysis of the Latin American Network Registry database from 1995 to 2011. J Assist Reprod Genet. 2018; 35: 1395–9.
Muteshi C.M., Ohuma E.O., Child T., Becker C.M. The effect of endometriosis on live birth rate and other reproductive outcomes in ART cycles: A cohort study. Hum Reprod Open. 2018; 2018: hoy016.
Muzii L., Achilli C., Bergamini V., Candiani M., Garavaglia E., Lazzeri L., et al. Comparison between the stripping technique and the combined excisional/ablative technique for the treatment of bilateral ovarian endometriomas: A multicentre RCT. Hum Reprod. 20l6a; 31: 339–44.
Muzii L., Achilli C., Lecce F., Bianchi A., Franceschetti S., Marchetti C., et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015; 103: 738–43.
Muzii L., Bellati F., Palaia I., Plotti F., Manci N., Zullo M.A., et al. Laparoscopic stripping of endometriomas: A randomized trial on different surgical techniques. Part I: clinical results. Hum Reprod. 2005; 20: 1981–6.
Muzii L., Di Tucci C., Achilli C., Di Donato V., Musella A., Palaia I., et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: A systematic review and meta-analysis. Am J Obstet Gynecol. 2016; 214: 203–11.
Namnoum A.B., Hickman T.N., Goodman S.B., Gehlbach D.L., Rock J.A. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril. 1995; 64: 898–902.
Nezhat C., Main J., Paka C., Nezhat A., Beygui R.E. Multidisciplinary treatment for thoracic and abdominopelvic endometriosis. JSLS. 2014; 18: e2014.00312.
Nezhat C., Santolaya J., Nezhat F.R., Nezhat C. Comparison of transvaginal sonography and bimanual pelvic examination in patients with laparoscopically confirmed endometriosis. J Am Assoc Gynecol Laparosc. 1994; 1: 127–130.
Nickkho-Amiry M., Savant R., Majumder K., Edi-O’sagie E., Akhtar M. The effect of surgical management of endometrioma on the IVF/ ICSI outcomes when compared with no treatment? A systematic review and meta-analysis. Arch Gynecol Obstet. 2018; 297: 1043–57.
Nisenblat V., Bossuyt P.M., Shaikh R., Farquhar C., Jordan V., Scheffers C.S., et al. Blood biomarkers for the noninvasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016; 5: CD012179.
Nisenblat V., Bossuyt P.M.M., Farquhar C., Johnson N., Hull M.L.; Cochrane Gynaecology and Fertility Group. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016; 2: CD009591.
Nnoaham K.E., Hummelshoj L., Kennedy S.H., Jenkinson C., Zondervan K.T.; World Endometriosis Research Foundation Women’s Health Symptom Survey Consortium. Developing symptom-based predictive models of endometriosis as a clinical screening tool: Results from a multicenter study. Fertil Steril. 2012; 98: 692–701.e5.
Nodler J.L., Harris H.R., Chavarro J.E., Frazier A.L., Missmer S.A. Dairy consumption during adolescence and endometriosis risk. Am J Obstet Gynecol. 2020; 222: 257.e1–16.
Nulsen J.C., Walsh S., Dumez S., Metzger D.A. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstet Gynecol. 1993; 82: 780–6.
Omland A.K., Tanbo T., Dale P.O., Abyholm T. Artificial insemination by husband in unexplained infertility compared with infertility associated with peritoneal endometriosis. Hum Reprod. 1998; 13: 2602–5.
Opoien H.K., Fedorcsak P., Byholm T., Tanbo T. Complete surgical removal of minimal and mild endometriosis improves outcome of subsequent IVF/ICSI treatment. Reprod Biomed Online. 2011; 23: 389–95.
Osuga Y., Seki Y., Tanimoto M., Kusumoto T., Kudou K., Terakawa N. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: A randomized, double-blind, placebo-controlled study. Fertil Steril. 2021; 115: 397–405.
Pabuccu R., Onalan G., Kaya C. GnRH agonist and antagonist protocols for stage I-–II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril. 2007; 88: 832–9.
Parazzini F., Cipriani S., Bravi F., Pelucchi C., Chiaffarino F., Ricci E., et al. A metaanalysis on alcohol consumption and risk of endometriosis. Am J Obstet Gynecol. 2013; 209: 106.e1–10.
Parazzini F., Vigano P., Candiani M., Fedele L. Diet and endometriosis risk: A literature review. Reprod Biomed Online. 2013; 26: 323–36.
Paulson J.D., Paulson J.N. Anterior vaginal wall tenderness (AVWT) as a physical symptom in chronic pelvic pain. JSLS. 2011; 15: 6–9.
Pavone M.E., Bulun S.E. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012; 98: 1370–9.
Pearce C.L., Templeman C., Rossing M.A., Lee A., Near A.M., Webb P.M., et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies. Lancet Oncol. 2012; 13: 385–94.
Perez-Lopez F.R., Villagrasa-Boli P., Munoz-Olarte M., Morera-Grau A., Cruz-Andres P., Hernandez A.V. Association between endometriosis and preterm birth in women with spontaneous conception or using assisted reproductive technology: A systematic review and meta-analysis of cohort studies. Reprod Sci. 2018; 25: 311–9.
Petraglia F., Hornung D., Seitz C., Faustmann T., Gerlinger C., Luisi S., et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet. 2012; 285: 167–73.
Pittaway D.E. The use of serial CA 125 concentrations to monitor endometriosis in infertile women. Am J Obstet Gynecol. 1990; 163: 1032–5.
Polyzos N.P., Fatemi H.M., Zavos A., Grimbizis G., Kyrou D., Velasco J.G., et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 2011; 9: 90.
Porpora M.G., Pallante D., Ferro A., Crisafi B., Bellati F., Benedetti Panici P. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: A long-term prospective study. Fertil Steril. 2010; 93: 716–21.
Proctor M., Latthe P., Farquhar C., Khan K., Johnson N.; Cochrane Gynaecology and Fertility Group. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2005; 4: CD001896.
Pundir J., Omanwa K., Kovoor E., Pundir V., Lancaster G., Barton-Smith P. Laparoscopic excision versus ablation for endometriosis- associated pain: An updated systematic review and meta-analysis. J Minim Invasive Gynecol. 2017; 24: 747–56.
Qiu Y., Yuan S., Wang H. Vitamin D status in endometriosis: A systematic review and meta-analysis. Arch Gynecol Obstet. 2020; 302: 141–52.
Razzi S., Luisi S., Ferretti C., Calonaci F., Gabbanini M., Mazzini M., et al. Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis. Eur J Obstet Gynecol Reprod Biol. 2007; 135: 188–90.
Redwine D.B. Endometriosis persisting after castration: Clinical characteristics and results of surgical management. Obstet Gynecol. 1994; 83: 405–13.
Ricci E., Vigano P., Cipriani S., Chiaffarino F., Bianchi S., Rebonato G., et al. Physical activity and endometriosis risk in women with infertility or pain: Systematic review and meta-analysis. Medicine (Baltimore). 2016; 95: e4957.
Ripps B.A., Martin D.C. Correlation of focal pelvic tenderness with implant dimension and stage of endometriosis. J Reprod Med. 1992; 37: 620–4.
Rodriguez-Purata J., Coroleu B., Tur R., Carrasco B., Rodriguez I., Barri P.N. Endometriosis and IVF: Are agonists really better? Analysis of 1180 cycles with the propensity score matching. Gynecol Endocrinol. 2013; 29: 859–62.
Roman J.D. Adolescent endometriosis in the Waikato region of New Zealand: A comparative cohort study with a mean follow-up time of 2.6 years. Aust N Z J Obstet Gynaecol. 2010; 50: 179–83.
Rossing M.A., Cushing-Haugen K.L., Wicklund K.G., Doherty J.A., Weiss N.S. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control. 2008; 19: 1357–64.
Sandstrom A., Bixo M., Johansson M., Backstrom T., Turkmen S. Effect of hysterectomy on pain in women with endometriosis: A population-based registry study. BJOG. 2020; 127: 1628–35.
Santulli P., Marcellin L., Menard S., Thubert T., Khoshnood B., Gayet V., et al. Increased rate of spontaneous miscarriages in endometriosis-affected women. Hum Reprod. 2016; 31: 1014–23.
Saraswat L., Ayansina D.T., Cooper K.G., Bhattacharya S., Miligkos D., Horne A.W., et al. Pregnancy outcomes in women with endometriosis: A national record linkage study. BJOG. 2017; 124: 444–52.
Sasamoto N., DePari M., Vitonis A.F., Laufer M.R., Missmer S.A., Shafrir A.L., et al. Evaluation of CA125 in relation to pain symptoms among adolescents and young adult women with and without surgically-confirmed endometriosis. PLoS One. 2020; 15: e0238043.
Sauerbrun-Cutler M.T., Alvero R. Short- and long-term impact of gonadotropin-releasing hormone analogue treatment on bone loss and fracture. Fertil Steril. 2019; 112: 799–803.
Seckin B., Ates M.C., Kirbas A., Yesilyurt H. Usefulness of hematological parameters for differential diagnosis of endometriomas in adolescents/young adults and older women. Int J Adolesc Med Health. 2018; 33. DOI: https://doi.org/10.1515/ijamh-2018-0078
Senapati S., Sammel M.D., Morse C., Barnhart K.T. Impact of endometriosis on in vitro fertilization outcomes: An evaluation of the Society for Assisted Reproductive Technologies Database. Fertil Steril. 2016; 106: 164–171.e1.
Seo J.W., Lee D.Y., Yoon B.K., Choi D. The efficacy of postoperative cyclic oral contraceptives after gonadotropin-releasing hormone agonist therapy to prevent endometrioma recurrence in adolescents. J Pediatr Adolesc Gynecol. 2017; 30: 223–7.
Seracchioli R., Mabrouk M., Manuzzi L., Vicenzi C., Frasca C., Elmakky A., et al. Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Hum Reprod. 2009; 24: 2729–35.
Serati M., Cattoni E., Braga A., Uccella S., Cromi A., Ghezzi F. Deep endometriosis and bladder and detrusor functions in women without urinary symptoms: A pilot study through an unexplored world. Fertil Steril. 2013; 100: 1332–6.
Shah D.K., Missmer S.A. Scientific investigation of endometriosis among adolescents. J Pediatr Adolesc Gynecol. 2011; 24: S18–9.
Shakiba K., Bena J.F., McGill K.M., Minger J., Falcone T. Surgical treatment of endometriosis: A 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008; 111: 1285–92.
Shaltout M.F., Elsheikhah A., Maged A.M., Elsherbini M.M., Zaki S.S., Dahab S., et al. A randomized controlled trial of a new technique for laparoscopic management of ovarian endometriosis preventing recurrence and keeping ovarian reserve. J Ovarian Res. 2019; 12: 66.
Smith J.S., Green J., Berrington de Gonzalez A., Appleby P., Peto J., Plummer M., et al. Cervical cancer and use of hormonal contraceptives: A systematic review. Lancet. 2003; 361: 1159–67.
Somigliana E., Vigano P., Benaglia L., Busnelli A., Paffoni A., Vercellini P. Ovarian stimulation and endometriosis progression or recurrence: A systematic review. Reprod Biomed Online. 2019; 38: 185–94.
Song S.Y., Park M., Lee G.W., Lee K.H., Chang H.K., Kwak S.M., et al. Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018; 231: 85–92.
Soriano D., Adler I., Bouaziz J., Zolti M., Eisenberg V.H., Goldenberg M., et al. Fertility outcome of laparoscopic treatment in patients with severe endometriosis and repeated in vitro fertilization failures. Fertil Steril. 2016; 106: 1264–9.
Stepniewska A., Pomini P., Guerriero M., Scioscia M., Ruffo G., Minelli L. Colorectal endometriosis: Benefits of long-term follow-up in patients who underwent laparoscopic surgery. Fertil Steril. 2010; 93: 2444–6.
Sukur Y.E., Ozmen B., Yakistiran B., Atabekoglu C.S., Berker B., Aytac R., et al. Endometrioma surgery is associated with increased risk of subsequent assisted reproductive technology cycle cancellation: A retrospective cohort study. J Obstet Gynaecol. 2021; 41: 259–62.
Sun P.R., Leng J.H., Jia S.Z., Lang J.H. Postmenopausal endometriosis: A retrospective analysis of 69 patients during a 20-year period. Chin Med J (Engl). 2013; 126: 4588–9.
Sutton C.J., Ewen S.P., Whitelaw N., Haines P. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril. 1994; 62: 696–700.
Tandoi I., Somigliana E., Riparini J., Ronzoni S., Vigano P., Candiani M. High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol. 2011; 24: 376–9.
Tang H., Wu R., Li X., Zhou Y., Liu Z., Wang C., et al. Curative effect of 1.88-mg and 3.75-mg gonadotrophin-releasing hormone agonist on stage III–IV endometriosis: Randomized controlled study. J Obstet Gynaecol Res. 2017; 43: 1550–4.
Tanmahasamut P., Rattanachaiyanont M., Angsuwathana S., Techatraisak K., Indhavivadhana S., Leerasiri P. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: A randomized controlled trial. Obstet Gynecol. 2012; 119: 519–26.
Taylor H.S., Giudice L.C., Lessey B.A., Abrao M.S., Kotarski J., Archer D.F., et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017; 377: 28–40.
Thomeer M.G., Steensma A.B., van Santbrink E.J., Willemssen F.E., Wielopolski P.A., Hunink M.G., et al. Can magnetic resonance imaging at 3.0-Tesla reliably detect patients with endometriosis? Initial results. J Obstet Gynaecol Res. 2014; 40: 1051–8.
Treloar S.A., Bell T.A., Nagle C.M., Purdie D.M., Green A.C. Early menstrual characteristics associated with subsequent diagnosis of endometriosis. Am J Obstet Gynecol. 2010; 202: 534.e1–6.
Tummon I.S., Asher L.J., Martin J.S., Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated a with minimal or mild endometriosis. Fertil Steril. 1997; 68: 8–12.
van der Houwen L.E., Schreurs A.M., Schats R., Heymans M.W., Lambalk C.B., Hompes P.G., et al. Efficacy and safety of intrauterine insemination in patients with moderate-to-severe endometriosis. Reprod Biomed Online. 2014; 28: 590–8.
Vanhie A., Peterse D., Beckers A., Cuellar A., Fassbender A., Meuleman C., et al. Plasma miRNAs as biomarkers for endometriosis. Hum Reprod. 2019; 34: 1650–60.
Vercellini P., Barbara G., Buggio L., Frattaruolo M.P., Somigliana E., Fedele L. Effect of patient selection on estimate of reproductive success after surgery for rectovaginal endometriosis: Literature review. Reprod Biomed Online. 2012; 24: 389–95.
Vercellini P., De Giorgi O., Mosconi P., Stellato G., Vicentini S., Crosignani P.G. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril. 2002; 77: 52–61.
Vercellini P., Eskenazi B., Consonni D., Somigliana E., Parazzini F., Abbiati A., et al. Oral contraceptives and risk of endometriosis: A systematic review and meta-analysis. Hum Reprod Update. 2011; 17: 159–70.
Vermeulen N., Le Clef N., Mcheik S., D’Angelo A., Tilleman K., Veleva Z., et al. Manual for ESHRE guideline development. 2019. URL: https://www.eshre.eu/Guidelines-and-Legal/Guidelines/ Guideline-development-process (date of access March 14, 2022).
Vicino M., Parazzini F., Cipriani S., Frontino G. Endometriosis in young women: The experience of GISE. J Pediatr Adolesc Gynecol. 2010; 23: 223–5.
Vigueras Smith A., Cabrera R., Kondo W., Ferreira H. Diaphragmatic endometriosis minimally invasive treatment: A feasible and effective approach. J Obstet Gynaecol. 2021; 41: 176–86.
Wentzensen N., Poole E.M., Trabert B., White E., Arslan A.A., Patel A.V., et al. Ovarian cancer risk factors by histologic subtype: An analysis from the ovarian cancer cohort consortium. J Clin Oncol. 2016; 34: 2888–98.
Wright J., Lotfallah H., Jones K., Lovell D. A randomized trial of excision versus ablation for mild endometriosis. Fertil Steril. 2005; 83: 1830–6.
Wu D., Hu M., Hong L., Hong S., Ding W., Min J., et al. Clinical efficacy of add-back therapy in treatment of endometriosis: A meta-analysis. Arch Gynecol Obstet. 2014; 290: 513–23.
Yang Y., Wang Y., Yang J., Wang S., Lang J. Adolescent endometriosis in China: A retrospective analysis of 63 cases. J Pediatr Adolesc Gynecol. 2012; 25: 295–9.
Yeung P. Jr, Sinervo K., Winer W., Albee R.B. Jr. Complete laparoscopic excision of endometriosis in teenagers: Is postoperative hormonal suppression necessary? Fertil Steril. 2011; 95: 1909–1912, 1912.e1.
Yong P.J., Matwani S., Brace C., Quaiattini A., Bedaiwy M.A., Albert A., et al. Endometriosis and ectopic pregnancy: A meta-analysis. J Minim Invasive Gynecol. 2020; 27: 352–361.e2.
Yoost J., LaJoie A.S., Hertweck P., Loveless M. Use of the levonorgestrel intrauterine system in adolescents with endometriosis. J Pediatr Adolesc Gynecol. 2013; 26: 120–4.
Younis J.S., Shapso N., Fleming R., Ben-Shlomo I., Izhaki I. Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: A systematic review and meta-analysis. Hum Reprod Update. 2019; 25: 375–91.
Zakhari A., Delpero E., McKeown S., Tomlinson G., Bougie O., Murji A. Endometriosis recurrence following post-operative hormonal suppression: A systematic review and meta-analysis. Hum Reprod Update. 2021; 27: 96–107.
Zhu X., Chen L., Deng X., Xiao S., Ye M., Xue M. A comparison between high-intensity focused ultrasound and surgical treatment for the management of abdominal wall endometriosis. BJOG. 2017; 124 (suppl 3): 53–8.
Zondervan K.T., Becker C.M., Missmer S.A. Endometriosis. N Engl J Med. 2020; 382: 1244–56.
Zorbas K.A., Economopoulos K.P., Vlahos N.F. Continuous versus cyclic oral contraceptives for the treatment of endometriosis: A systematic review. Arch Gynecol Obstet. 2015; 292: 37–43.
Zucchetto A., Serraino D., Polesel J., Negri E., De Paoli A., Dal Maso L., et al. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev. 2009; 18: 316–21.